Status:
COMPLETED
A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans
Lead Sponsor:
Abbott
Conditions:
Healthy
Eligibility:
MALE
18-40 years
Phase:
PHASE1
Brief Summary
The objective of this study is to determine the amount of ABT-614 in the cerebral spinal fluid and blood after administration of a single dose and after administration of daily doses for 14 days in he...
Eligibility Criteria
Inclusion
- Healthy male subjects between 18 and 40 years of age
Exclusion
- History of bleeding disorders or deep vein thrombosis (DVT)
- Previous gastrointestinal (GI) surgery or chronic GI disease
- History of spinal surgery
- History of significant, chronic low back pain
- History of frequent headaches
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00959816
Start Date
August 1 2009
Last Update
November 2 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 22445
San Antonio, Texas, United States, 78217